Trial Profile
A randomized, open-label study of the effect of CellCept on the pharmacokinetics of tacrolimus and clinical outcome in liver transplant patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- 26 Feb 2010 New trial record